![]() |
市場調査レポート
商品コード
1467731
開腹手術用スポンジ市場レポート:技術、無菌性、手技、エンドユーザー、地域別、2024~2032年Laparotomy Sponges Market Report by Technology (Radiopaque, Traditional, Radio-Frequency Identification ), Sterility, Procedure, End-User, and Region 2024-2032 |
||||||
カスタマイズ可能
|
開腹手術用スポンジ市場レポート:技術、無菌性、手技、エンドユーザー、地域別、2024~2032年 |
出版日: 2024年04月08日
発行: IMARC
ページ情報: 英文 137 Pages
納期: 2~3営業日
|
世界の開腹手術用スポンジ市場規模は2023年に10億790万米ドルに達しました。今後、IMARC Groupは、市場は2032年までに17億3,350万米ドルに達し、2024~2032年の間に6%の成長率(CAGR)を示すと予測しています。
開腹手術用スポンジ(吸収パッド)は、医療セグメントで切開部や手術部周辺の余分な液体や血液を吸収し、硬膜下血腫を排出するために使用されます。綿、レーヨン、ナイロンポリエステルを使用しており、医療品質と衛生基準を満たし、体液を最大限に吸収することができます。これらのスポンジの用途は、切開部位の洗浄や保湿にも及びます。また、外科医が組織や臓器を傷つけることなく手作業で摘出する際にも使用されます。
高齢者人口における腹部疾患の有病率の高まりと外科手術件数の増加が、市場成長を促進する主要要因です。さらに、大衆の間で結腸がん、ヘルニア、虫垂炎、膵炎、消化性潰瘍などの疾患の症例が大幅に増加しており、開腹手術の必要性が高まっています。これとは別に、病院や医療センターで行われる帝王切開手術の増加も、開腹手術用スポンジの使用率を高めています。さらに、熱融着硫酸バリウムマーカー付きパッドの導入やX線の視認性向上など、開腹手術用スポンジのさまざまな技術革新も市場成長に影響を与える要因となっています。さらに、開腹手術用スポンジは手術中に意図せず体内に留置される可能性があるため、メーカーは容易に検出可能なバーコード付きスポンジを開発し、手術後の留置事例を減少させています。
The global laparotomy sponges market size reached US$ 1,007.9 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 1,733.5 Million by 2032, exhibiting a growth rate (CAGR) of 6% during 2024-2032.
Laparotomy sponges, or absorbent pads, are used in the healthcare sector for absorbing excess fluid or blood and evacuating subdural hematoma around an incision or a surgical area. They are made using cotton, rayon and nylon polyester that meets the medical quality and hygiene standards and allows the maximum absorption of fluids. The application of these sponges further extends to cleaning and retaining moisture at an incision site. They are also used by surgeons for gripping and manually removing tissue or an organ without causing any potential harm.
The growing prevalence of abdominal disorders among the geriatric population and an increase in the number of surgical procedures are the key factors driving the market growth. Furthermore, there has been a significant rise in the cases of diseases such as colon cancer, hernia, appendicitis, pancreatitis, peptic ulcers among the masses that have led to a growing need for laparotomy surgeries. Apart from this, an increasing number of cesarean operations conducted in hospitals and medical centers have also increased the utilization of laparotomy sponges. Additionally, various innovations in laparotomy sponges, such as the introduction of pads with heat bonded barium sulfate markers and enhanced X-ray visibility, represent another factor influencing the market growth. Moreover, as laparotomy sponges can be unintentionally retained in the body during operations, manufacturers have developed easily detectable and barcode tagged sponges that can reduce the cases of post-operation retentions.
IMARC Group provides an analysis of the key trends in each sub-segment of the global laparotomy sponges market report, along with forecasts at the global and regional level from 2024-2032. Our report has categorized the market based on technology, sterility, procedure and end-user.
Radiopaque
Traditional
Radio-Frequency Identification (RFID)
Sterile Laparotomy Sponges
Non-Sterile Laparotomy Sponges
Pre-Washed Laparotomy Sponge
Non-Washed Laparotomy Sponge
Hospitals
Clinics
Multispecialty Surgical Centers
Ambulatory Surgical Centers
Others
North America
Europe
Asia Pacific
Middle East and Africa
Latin America
The report has also analysed the competitive landscape of the market with some of the key players being Medtronic, Owens & Minor, Integra LifeSciences, Medical Action Industries, AdvaCare Pharma, B. Braun Melsungen, Cardinal Health, Dynarex Corporation, DeRoyal, BSN Medical GmbH, Dukal Corporation, Stryker Corporation, etc.